Agenus Inc (NQ: AGEN )

3.230 USD +0.200 (+6.60%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist

Price and Volume

Volume	2,275,874
Open	3.050
Bid (Size)	3.220 (101)
Ask (Size)	3.240 (7)
Prev. Close	3.030
Today's Range	3.025 - 3.230
52wk Range	2.400 - 5.950
Shares Outstanding	222,441,009
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Agenus Corporate Update and First Quarter 2021 Financial Report

May 06, 2021

Accurate Diagnostic Solutions Remain Vital to Overcoming the Pandemic

May 04, 2021

FinancialBuzz.com News Commentary

Performance

YTD	N/A	N/A
1 Month	+23.28%	+23.28%
3 Month	-29.78%	-29.78%
6 Month	-16.75%	-16.75%
1 Year	+29.20%	+29.20%

More News

MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders

May 03, 2021

Agenus to Present at the 2021 ASCO Annual Meeting

April 28, 2021

Agenus to Provide Corporate Update and First Quarter 2021 Financial Report

April 22, 2021

Agenus Submits Balstilimab Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer

April 19, 2021

Agenus Doses First Cancer Patient with iNKT Cell Therapy

April 14, 2021

New Clinical Responses for AGEN1181 Presented at AACR

April 10, 2021

Innovative Diagnostic Methods Remains Vital in the Fight Against Cancer

April 09, 2021

Agenus to Participate in Webcast Hosted by William Blair on AGEN1181 and Balstilimab AACR Presentations

April 06, 2021

7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts

May 12, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.